Fresenius Medical Care AG... (FMS)
Fresenius Medical Care AG & Co. KGaA Statistics
Share Statistics
Fresenius Medical Care AG & Co. KGaA has 586.83M shares outstanding. The number of shares has increased by 0% in one year.
Shares Outstanding | 586.83M |
Shares Change (YoY) | 0% |
Shares Change (QoQ) | 0% |
Owned by Institutions (%) | 11.59% |
Shares Floating | 586.39M |
Failed to Deliver (FTD) Shares | 5 |
FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 805.37K, so 0.14% of the outstanding shares have been sold short.
Short Interest | 805.37K |
Short % of Shares Out | 0.14% |
Short % of Float | 0.14% |
Short Ratio (days to cover) | 2.8 |
Valuation Ratios
The PE ratio is 23.85 and the forward PE ratio is 9.58. Fresenius Medical Care AG & Co. KGaA's PEG ratio is 3.12.
PE Ratio | 23.85 |
Forward PE | 9.58 |
PS Ratio | 0.66 |
Forward PS | 0.6 |
PB Ratio | 0.88 |
P/FCF Ratio | 7.61 |
PEG Ratio | 3.12 |
Enterprise Valuation
Fresenius Medical Care AG & Co. KGaA has an Enterprise Value (EV) of 16.29B.
EV / Earnings | 30.28 |
EV / Sales | 0.84 |
EV / EBITDA | 5.08 |
EV / EBIT | 11.7 |
EV / FCF | 9.66 |
Financial Position
The company has a current ratio of 1.4, with a Debt / Equity ratio of 0.75.
Current Ratio | 1.4 |
Quick Ratio | 1.03 |
Debt / Equity | 0.75 |
Total Debt / Capitalization | 42.96 |
Cash Flow / Debt | 0.22 |
Interest Coverage | 3.42 |
Financial Efficiency
Return on equity (ROE) is 0.04% and return on capital (ROIC) is 3.65%.
Return on Equity (ROE) | 0.04% |
Return on Assets (ROA) | 0.02% |
Return on Capital (ROIC) | 3.65% |
Revenue Per Employee | $173,396.01 |
Profits Per Employee | $4,823.77 |
Employee Count | 111,513 |
Asset Turnover | 0.58 |
Inventory Turnover | 7.05 |
Taxes
Income Tax | 316.06M |
Effective Tax Rate | 0.3 |
Stock Price Statistics
The stock price has increased by 28.53% in the last 52 weeks. The beta is 0.91, so Fresenius Medical Care AG & Co. KGaA's price volatility has been higher than the market average.
Beta | 0.91 |
52-Week Price Change | 28.53% |
50-Day Moving Average | 24.02 |
200-Day Moving Average | 21.56 |
Relative Strength Index (RSI) | 58.14 |
Average Volume (20 Days) | 282.1K |
Income Statement
In the last 12 months, Fresenius Medical Care AG & Co. KGaA had revenue of 19.34B and earned 537.91M in profits. Earnings per share was 1.83.
Revenue | 19.34B |
Gross Profit | 4.76B |
Operating Income | 1.39B |
Net Income | 537.91M |
EBITDA | 3.21B |
EBIT | 1.39B |
Earnings Per Share (EPS) | 1.83 |
Balance Sheet
The company has 1.15B in cash and 10.98B in debt, giving a net cash position of -9.83B.
Cash & Cash Equivalents | 1.15B |
Total Debt | 10.98B |
Net Cash | -9.83B |
Retained Earnings | 11.27B |
Total Assets | 33.57B |
Working Capital | 2.26B |
Cash Flow
In the last 12 months, operating cash flow was 2.39B and capital expenditures -699.36M, giving a free cash flow of 1.69B.
Operating Cash Flow | 2.39B |
Capital Expenditures | -699.36M |
Free Cash Flow | 1.69B |
FCF Per Share | 5.75 |
Margins
Gross margin is 24.6%, with operating and profit margins of 7.2% and 2.78%.
Gross Margin | 24.6% |
Operating Margin | 7.2% |
Pretax Margin | 5.47% |
Profit Margin | 2.78% |
EBITDA Margin | 16.58% |
EBIT Margin | 7.2% |
FCF Margin | 8.72% |
Dividends & Yields
FMS pays an annual dividend of $0.63, which amounts to a dividend yield of 2.89%.
Dividend Per Share | $0.63 |
Dividend Yield | 2.89% |
Dividend Growth (YoY) | 2.6% |
Payout Ratio | 64.06% |
Earnings Yield | 7.38% |
FCF Yield | 11.6% |
Analyst Forecast
The average price target for FMS is $25, which is 0.9% higher than the current price. The consensus rating is "Hold".
Price Target | $25 |
Price Target Difference | 0.9% |
Analyst Consensus | Hold |
Analyst Count | 1 |
Stock Splits
The last stock split was on Dec 4, 2012. It was a forward split with a ratio of 2:1.
Last Split Date | Dec 4, 2012 |
Split Type | forward |
Split Ratio | 2:1 |
Scores
Altman Z-Score | 1.75 |
Piotroski F-Score | 6 |